Identification and characterization of GLP1 receptorexpressing cells using a new transgenic mouse model
Li Y, Rao PK, Wen R, Song Y, Muir D, Wallace P, et al
Obesity, in particular, exacerbates PsD severity and treatment resistance, underscoring the need for integrated therapeutic strategies
Rev Colom Cienc Pecua
It remains to be seen, however, whether Lilly will be able to maintain the current pace of growth while Mounjaro and Zepbound prices come under pressure, and whether production capacity, together with a diversified pipeline and an active acquisition strategy, will be able to offset the possible impact on margins
Recent FDA approvals and indications for products containing semaglutide include the reduction of cardiovascular risk in patients with type 2 diabetes and body weight reduction for obesity